English
Back
Download
Log in to access Online Inquiry
Back to the Top

Update

$Aldeyra Therapeutics (ALDX.US)$ Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
5990 Views
Comment
Sign in to post a comment
    4491
    Followers
    25
    Following
    64K
    Visitors
    Follow
    Discussing
    Trump 2.0 countdown: What's the next big opportunity in the markets?
    ▪️Could Trump's cryptocurrency policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese Show More